Yuhan Corporation

Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

Collaborator, Phase 4, Active, not recruiting, 2025, 408 people, 9 Jan 2025, clinicaltrials.gov

NCT05730621

Phase 4, Completed, 2023, 68 people, 16 Feb 2023, clinicaltrials.gov

NCT05579626

Collaborator, Phase 4, Enrolling by invitation, 2023, 4,000 people, 14 Oct 2022, clinicaltrials.gov

NCT04056169

Phase 4, Completed, 2017, 50 people, 14 Aug 2019, clinicaltrials.gov

NCT03217409

Phase 4, Completed, 2017, 85 people, 14 Jul 2017, clinicaltrials.gov

NCT03116516

Phase 1, Completed, 2017, 62 people, 17 Apr 2017, clinicaltrials.gov

NCT03067688

Phase 3, Completed, 2017, 202 people, 1 Mar 2017, clinicaltrials.gov

NCT02968160

Phase 4, Terminated, 2016, 55 people, 18 Nov 2016, clinicaltrials.gov

NCT02951962

Phase 1, Completed, 2016, 60 people, 1 Nov 2016, clinicaltrials.gov

NCT02817347

Phase 1/2, Terminated, 2016, 135 people, 29 Jun 2016, clinicaltrials.gov

NCT02759198

Phase 2, Completed, 2016, 456 people, 3 May 2016, clinicaltrials.gov

NCT02608242

Phase 1, Terminated, 2015, 123 people, 18 Nov 2015, clinicaltrials.gov

NCT02586129

Phase 3, Completed, 2015, 249 people, 26 Oct 2015, clinicaltrials.gov

NCT02294643

Collaborator, Phase 3, Completed, 2009, 220 people, 19 Nov 2014, clinicaltrials.gov

NCT02233218

Phase 1, Completed, 2014, 60 people, 8 Sept 2014, clinicaltrials.gov

NCT02125227

Phase 1, Completed, 2014, 56 people, 29 Apr 2014, clinicaltrials.gov

NCT01992601

Phase 1, Completed, 2012, 48 people, 25 Nov 2013, clinicaltrials.gov

NCT01975961

Phase 1, Completed, 2013, 185 people, 5 Nov 2013, clinicaltrials.gov

NCT01914432

Phase 3, Completed, 2013, 210 people, 2 Aug 2013, clinicaltrials.gov

NCT01750437

Phase 2, Completed, 2013, 149 people, 17 Dec 2012, clinicaltrials.gov